Choose an M&A Adviser for an ABA Practice Sale

To choose an M&A adviser or business broker for an ABA practice sale, define the work you need, then compare candidates on deal-size and healthcare experience, the people doing the work, buyer access, process design, valuation discipline, registration or exemption analysis, conflicts, confidentiality, references, fees, exclusivity, expenses, termination, and tail obligations. Verify factual claims independently and hire separate legal, tax, accounting, clinical, payer, privacy, and wealth advisers where the sale process requires authority the broker does not have.

The right adviser depends on the sale you are actually considering

One owner may need help deciding whether to sell at all. Another may already have an unsolicited offer and need competition. A third may want a confidential market process, a minority investment, a partner buyout, or a local succession plan. Those assignments require different networks, teams, timelines, and economics. The biggest firm and the most familiar name are not automatically the best fit.

Learning how to choose an M&A adviser or business broker for an ABA practice sale begins with defining the problem before listening to a pitch. Write down the desired transaction, approximate size, likely buyer types, geographic scope, confidentiality needs, owner role after closing, timing, and nonfinancial priorities. A candidate should respond to that brief rather than replacing it with the firm's favorite process.

Clarify the role and the work product

Ask what the adviser will actually do: readiness assessment, valuation framing, marketing materials, buyer research, outreach, confidentiality agreements, bid comparison, management preparation, diligence coordination, negotiation support, closing coordination, or post-close follow-up. Identify the deliverables, schedule, assumptions, data required from the practice, and work that remains with management or other advisers.

The SBA sell-your-business guidance recommends valuation, qualified advice, and a comprehensive attorney-reviewed agreement. The SBA acquisition page offers broad small-business transaction orientation. Neither source endorses a broker, defines a healthcare sale process, or says an owner must hire one. The engagement should fill a real capability gap and leave legal, tax, accounting, clinical, payer, privacy, and securities judgments with qualified professionals.

Meet the team that will do the work

A senior rainmaker may lead the pitch while analysts and associates run the process. Ask who builds the financial model, writes the confidential materials, contacts buyers, joins management meetings, manages the data room, negotiates key terms, and stays through closing. Review current workloads, escalation paths, expected response time, and what happens if a team member leaves.

Request examples of anonymized work product suited to a similar assignment, then focus on reasoning rather than appearance. Can the team explain revenue recognition, authorization and credentialing lags, claims aging, clinician capacity, supervision, payer concentration, location economics, owner dependence, and quality infrastructure without turning them into slogans? ABA familiarity should appear in the questions asked, not only in a logo slide.

Comparable experience needs a denominator

A candidate may cite healthcare, behavioral-health, autism-services, or ABA transactions. Ask how many, over what period, at what size, in which role, with which buyer types, and how many closed. Clarify whether the firm represented the seller, buyer, investor, or lender and whether the named person was on the working team. A long transaction list can include assignments quite unlike the owner's practice.

References are most useful when questions are specific. Ask former clients about preparation burden, candor on valuation, buyer quality, confidentiality, communication during setbacks, handling of conflicts, fee surprises, and performance after the letter of intent. A closed deal is not proof that the process protected care, staff, or the owner's priorities.

Verify registration and exemption claims with counsel

Transaction-related compensation and securities activity can raise broker-dealer questions. The SEC small-business broker-dealer resource explains that a person or firm may need registration when paid transaction-related compensation for certain securities transactions and points users to registration tools. The federal statute in 15 U.S.C. 78o(b)(13) contains a registration exemption for qualifying M&A brokers and also lists excluded activities and conditions.

That exemption is not a universal badge for every business broker, transaction, service, or state. Antifraud law, state requirements, contract duties, and fact-specific analysis still matter. Securities counsel should review the candidate's role, compensation, parties, deal form, buyer activity, financing, custody, conflicts, and state footprint. Ask the candidate to state the legal basis it relies on in writing.

Use public tools, then ask about what they do not show

Investor.gov's Check Out Your Investment Professional tool can show registration and disciplinary information for covered investment professionals and firms and may redirect to BrokerCheck. FINRA's BrokerCheck explanation describes information available about registered brokerage firms and professionals, including employment, qualifications, operations, and certain disclosures.

These tools are valuable when the person or firm appears in their systems. Absence does not by itself establish wrongdoing because an exemption or different regulatory category may apply; presence does not prove ABA expertise, good judgment, or a suitable engagement. Confirm identity, registration status, firm affiliation, disclosures, state records, litigation and references with qualified counsel and your own diligence.

Read the fee in dollars across several outcomes

Engagements may include a retainer, monthly fee, success fee, minimum fee, tiered percentage, expense reimbursement, financing fee, rollover or earnout treatment, or additional payment for another service. Calculate the fee in dollars under several purchase prices and structures. Define whether assumed debt, rollover equity, seller notes, earnouts, real estate, working capital, and post-closing payments enter the fee base and when each fee becomes due.

Ask which fees are credited, refundable, or owed after termination. Review exclusivity, term, renewal, termination, cause, assignment, indemnification, limitation of liability, expense approval, and the tail. A tail should identify the buyers and transaction types it covers, its duration, notice mechanics, and how a later owner-led or differently structured transaction is treated. Counsel should explain the actual engagement before it is signed.

Conflicts should be visible before the buyer list is built

Ask whether the firm represents likely buyers, lenders, investors, competitors, or other sellers in the market. Determine whether it receives referral, financing, insurance, wealth-management, consulting, or other compensation tied to the process. If the firm might represent both sides, arrange financing, or participate economically after closing, require clear disclosure and independent review.

The adviser may reasonably have repeat buyer relationships; those relationships can also shape attention and access. Ask how buyers are selected, how inbound interest is handled, whether every qualified bid reaches the seller, and who controls messaging. The owner should know which incentives reward price, speed, certainty, financing, continued employment, or a particular counterparty.

The marketing story must survive diligence

A good adviser helps the practice explain its history, strengths, risks, and operating model clearly. That does not mean turning every backlog into demand, every authorization into revenue, or every adjustment into recurring earnings. Ask how the adviser verifies data, distinguishes management projections from historical results, handles unsuccessful months, and corrects materials when a source changes.

The OIG General Compliance Program Guidance is voluntary and nonbinding. Its themes of leadership, risk assessment, incentives, reporting, auditing, investigation, and corrective action can help test whether the sale process rewards candor. That guidance neither approves marketing material nor certifies claims. Owners remain responsible for truthful information and for routing payer, billing, compliance, accounting, legal, and clinical questions to qualified authorities.

Confidentiality is an operating design, not one NDA

Map when the practice name, location, payer mix, employee data, family information, financial detail, and client-level evidence become available, to whom, and under which controls. Ask how the adviser screens buyers, marks documents, runs staged disclosure, logs access, verifies recipients, handles downloads, responds to a leak, and closes access when a bidder exits. Employee and family communication should follow an approved transition plan, not market rumor.

The transaction context in 45 CFR 164.501 is bounded and does not authorize unrestricted PHI disclosure. HHS business-associate guidance explains that some service relationships involving PHI require appropriate agreements and safeguards. Privacy and security leaders should approve the party, purpose, minimum necessary scope, agreement, platform, retention, and deletion route. A broker should not decide that boundary alone.

Care continuity belongs in the selection conversation

Ask candidates how they plan management meetings, diligence requests, buyer visits, employee communication, payer change-of-ownership work, and closing around actual service operations. A process that consumes every leader for six months can weaken supervision, claims follow-up, hiring, and family communication. The practice needs a cadence, decision owner, escalation route, and protected clinical capacity.

The BACB Ethics Code continues to apply to certificants within its scope, including duties concerning truthfulness, competence, conflicts, client welfare, documentation, supervision, and transition. Nothing in the code prescribes a sale adviser. The candidate should respect qualified clinical authority, avoid promises about treatment or staffing it cannot make, and leave room for an orderly transition even when speed would improve the transaction calendar.

A fictional bake-off reveals different kinds of fit

North Lantern ABA is fictional. It interviews three advisers. One has a national buyer network but assigns the work to a crowded generalist team. One knows local business owners but has never managed payer or privacy diligence. The third has a smaller buyer list, a senior working team, clear healthcare references, and a process that matches the practice's size. Its fee is not the lowest.

The owner asks each firm to respond to the same brief, fee scenarios, conflict questions, team interviews, and anonymized data exercise. Securities counsel reviews registration and exemption issues; transaction counsel reviews the engagement. The owner selects the third firm and records why. The outcome is not a recommendation for smaller firms. It shows how comparable evidence makes a polished pitch easier to evaluate.

Choose the adviser, then keep governing the process

The final answer to how to choose an M&A adviser or business broker for an ABA practice sale should fit on one decision page: assignment, team, relevant experience, references, process, buyer reach, regulatory analysis, conflicts, confidentiality, fee scenarios, engagement terms, continuity plan, and unresolved risks. Include the reasons a candidate was not selected so the decision remains understandable after negotiations become busy.

Hiring an adviser transfers work, not ownership of the decision. Set a weekly cadence, approval rights for materials and outreach, buyer-list controls, correction process, fee tracking, confidentiality reviews, and gates for moving from interest to diligence to exclusivity. A strong adviser can widen the owner's choices. The owner, board, and qualified advisers still decide whether any choice is good enough to sign.

How to Choose an M&A Adviser or Business Broker for an ABA Practice Sale